{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:38:28Z","timestamp":1788871108292,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.vetimm.2006.07.004","type":"journal-article","created":{"date-parts":[[2006,9,6]],"date-time":"2006-09-06T10:32:41Z","timestamp":1157538761000},"page":"168-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate"],"prefix":"10.1016","volume":"114","author":[{"given":"Mayu","family":"Isotani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Yagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Hikosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukimi","family":"Washizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Bonkobara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2006.07.004_bib1","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2006.07.004_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jlb.67.2.135","article-title":"c-kit and c-kit mutations in mastocytosis and other hematological diseases","volume":"67","author":"Boissan","year":"2000","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.vetimm.2006.07.004_bib3","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.167.12.6893","article-title":"Epidermal langerhans cell-targeted gene expression by a dectin-2 promoter","volume":"167","author":"Bonkobara","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2006.07.004_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","article-title":"Stem cell factor and hematopoiesis","volume":"90","author":"Broudy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2006.07.004_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.2003.04362.x","article-title":"Incidence and prognosis of c-kit and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias","volume":"121","author":"Care","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vetimm.2006.07.004_bib6","series-title":"Diseases of the Cat: Medicine and Surgery","first-page":"406","article-title":"Tumors and tumor-like lesions","author":"Carpenter","year":"1987"},{"key":"10.1016\/j.vetimm.2006.07.004_bib7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2460\/ajvr.2002.63.1129","article-title":"Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats","volume":"63","author":"Dank","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2006.07.004_bib8","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2460\/ajvr.2002.63.1718","article-title":"Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs","volume":"63","author":"Downing","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2006.07.004_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2141.1999.01449.x","article-title":"c-kit protooncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia","volume":"105","author":"Gari","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vetimm.2006.07.004_bib10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/sj.leu.2403870","article-title":"Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia","volume":"19","author":"Goemans","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.vetimm.2006.07.004_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.06.060","article-title":"Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis","volume":"129","author":"Hartmann","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vetimm.2006.07.004_bib12","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2002.20.6.1692","article-title":"Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies","volume":"20","author":"Heinrich","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.vetimm.2006.07.004_bib13","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood-2004-06-2068","article-title":"KIT exon 8 mutations associated with core binding factor (CBF)\u2013acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor","volume":"105","author":"Kohl","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2006.07.004_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1939-1676.2005.tb02778.x","article-title":"A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor-bearing cats","volume":"19","author":"Lachowicz","year":"2005","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2006.07.004_bib15","first-page":"2755","article-title":"Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies","volume":"9","author":"London","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2006.07.004_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","article-title":"Classes of c-kit activating mutations: proposed mechanisms of action and implications for disease classification and therapy","volume":"25","author":"Longley","year":"2001","journal-title":"Leukemia Res."},{"key":"10.1016\/j.vetimm.2006.07.004_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1523-1747.1999.00488.x","article-title":"Clustering of activating mutations in c-kit's juxtamembrane coding region in canine mast cell neoplasms","volume":"112","author":"Ma","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.vetimm.2006.07.004_bib18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.leu.2403803","article-title":"Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)","volume":"19","author":"Nanri","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.vetimm.2006.07.004_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.leu.2403889","article-title":"Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a c-kit exon 8 mutation","volume":"19","author":"Nanri","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.vetimm.2006.07.004_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.bi.57.070188.002303","article-title":"Growth factor receptor tyrosine kinases","volume":"57","author":"Yarden","year":"1988","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.vetimm.2006.07.004_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1354\/vp.39-5-529","article-title":"Mutations in the juxtamembrane domain of c-kit are associated with higher grade mast cell tumors in dogs","volume":"39","author":"Zemke","year":"2002","journal-title":"Vet. Pathol."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242706001978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242706001978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:19:47Z","timestamp":1759043987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242706001978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0165242706001978"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2006.07.004","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2006.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}